PLEKHG4B | Pleckstrin homology domain containing, family G (with RhoGef domain) member 4B | | ![](/images/36274/ihc_selected_60x60.jpg) | ![](/images/58157/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/36274/75197_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
LRRC14B | Leucine rich repeat containing 14B | | ![](/images/38046/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/38046/79242_B_9_2_rna_selected_60x60.jpg) | Group enriched |
CCDC127 | Coiled-coil domain containing 127 | | ![](/images/45052/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/45052/103886_B_8_4_rna_selected_60x60.jpg) | Mixed |
SDHA | Succinate dehydrogenase complex, subunit A, flavoprotein (Fp) | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | ![](/images/41981/ihc_cell_selected_60x60.jpg) | ![](/images/41981/124438_A_3_3_rna_selected_60x60.jpg) | Expressed in all |
PDCD6 | Programmed cell death 6 | Plasma proteins
| ![](/images_static/rna_center.gif) | ![](/images/47221/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Expressed in all |
AHRR | Aryl-hydrocarbon receptor repressor | Transcription factors
| ![](/images/19614/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/19614/44548_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
C5orf55 | Chromosome 5 open reading frame 55 | | ![](/images/43680/ihc_selected_60x60.jpg) | ![](/images/43680/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/43680/99675_B_9_7_rna_selected_60x60.jpg) | Mixed |
EXOC3 | Exocyst complex component 3 | | ![](/images/17459/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/17459/39665_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
CTD-2228K2.5 | Uncharacterized protein | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Expressed in all |
SLC9A3 | Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 | Predicted membrane proteins Transporters
| | | ![](/images_static/rna_center.gif) | ![](/images/36493/78436_B_9_2_rna_selected_60x60.jpg) | Group enriched |
CEP72 | Centrosomal protein 72kDa | | ![](/images/58235/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/58235/132376_B_8_6_rna_selected_60x60.jpg) | Mixed |
TPPP | Tubulin polymerization promoting protein | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/36575/141822_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
AC026740.1 | Uncharacterized protein | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
ZDHHC11 | Zinc finger, DHHC-type containing 11 | Enzymes Predicted membrane proteins
| ![](/images/57886/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/57886/140178_B_3_2_rna_selected_60x60.jpg) | Mixed |
ZDHHC11B | Zinc finger, DHHC-type containing 11B | Enzymes Predicted membrane proteins
| ![](/images/57886/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/57886/140178_B_3_2_rna_selected_60x60.jpg) | Mixed |
BRD9 | Bromodomain containing 9 | | ![](/images/21465/ihc_selected_60x60.jpg) | ![](/images/21465/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/21465/48136_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
TRIP13 | Thyroid hormone receptor interactor 13 | | ![](/images/53093/ihc_selected_60x60.jpg) | ![](/images/53093/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/53093/144776_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
RP11-661C8.3 | Uncharacterized protein | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Not detected |
NKD2 | Naked cuticle homolog 2 (Drosophila) | | ![](/images/49463/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/49463/112641_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
SLC12A7 | Solute carrier family 12 (potassium/chloride transporter), member 7 | Plasma proteins Predicted membrane proteins Transporters
| ![](/images/41652/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/41652/87092_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
SLC6A19 | Solute carrier family 6 (neutral amino acid transporter), member 19 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| ![](/images/37415/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/37415/79704_B_9_5_rna_selected_60x60.jpg) | Group enriched |
SLC6A18 | Solute carrier family 6 (neutral amino acid transporter), member 18 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/11885/144156_B_8_7_rna_selected_60x60.jpg) | Tissue enriched |
TERT | Telomerase reverse transcriptase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
CLPTM1L | CLPTM1-like | Predicted membrane proteins
| ![](/images/14791/ihc_selected_60x60.jpg) | ![](/images/14791/if_selected_60x60.jpg) | ![](/images/14791/ihc_cell_selected_60x60.jpg) | ![](/images/14791/34209_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
SLC6A3 | Solute carrier family 6 (neurotransmitter transporter), member 3 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| ![](/images/13602/ihc_selected_60x60.jpg) | ![](/images/13602/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/13602/30986_B_7_8_rna_selected_60x60.jpg) | Not detected |
LPCAT1 | Lysophosphatidylcholine acyltransferase 1 | Enzymes Predicted membrane proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/12501/29971_B_8_6_rna_selected_60x60.jpg) | Expressed in all |
MRPL36 | Mitochondrial ribosomal protein L36 | Mitochondrial proteins Ribosomal proteins
| | ![](/images_static/na_center.gif) | ![](/images/47238/ihc_cell_selected_60x60.jpg) | ![](/images/47238/105547_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
NDUFS6 | NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kDa (NADH-coenzyme Q reductase) | Mitochondrial proteins Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/64221/144026_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
IRX4 | Iroquois homeobox 4 | Plasma proteins Transcription factors
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
IRX2 | Iroquois homeobox 2 | Transcription factors
| ![](/images/54669/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/54669/125409_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
C5orf38 | Chromosome 5 open reading frame 38 | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
IRX1 | Iroquois homeobox 1 | Plasma proteins Transcription factors
| ![](/images/43160/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/43160/93427_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
ADAMTS16 | ADAM metallopeptidase with thrombospondin type 1 motif, 16 | Enzymes Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
KIAA0947 | KIAA0947 | | ![](/images/54452/ihc_selected_60x60.jpg) | ![](/images/54452/if_selected_60x60.jpg) | ![](/images/54452/ihc_cell_selected_60x60.jpg) | ![](/images/54452/127471_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
MED10 | Mediator complex subunit 10 | | ![](/images/42795/ihc_selected_60x60.jpg) | ![](/images/42795/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/42795/93536_B_7_8_rna_selected_60x60.jpg) | Expressed in all |
UBE2QL1 | Ubiquitin-conjugating enzyme E2Q family-like 1 | Enzymes
| ![](/images/57414/ihc_selected_60x60.jpg) | ![](/images/57414/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/57414/133872_B_2_1_rna_selected_60x60.jpg) | Tissue enhanced |
NSUN2 | NOP2/Sun RNA methyltransferase family, member 2 | Disease related genes Enzymes Potential drug targets
| | | ![](/images/37896/ihc_cell_selected_60x60.jpg) | ![](/images/37896/76891_B_8_6_rna_selected_60x60.jpg) | Expressed in all |
SRD5A1 | Steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) | Cancer-related genes Enzymes FDA approved drug targets Predicted membrane proteins
| ![](/images/51402/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/51402/116935_B_9_1_rna_selected_60x60.jpg) | Mixed |
PAPD7 | PAP associated domain containing 7 | Enzymes Predicted membrane proteins
| | | | ![](/images/46742/105728_B_8_4_rna_selected_60x60.jpg) | Expressed in all |
ADCY2 | Adenylate cyclase 2 (brain) | Enzymes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/38015/84094_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
C5orf49 | Chromosome 5 open reading frame 49 | | ![](/images/43759/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/43759/102185_B_8_1_rna_selected_60x60.jpg) | Group enriched |
MTRR | 5-methyltetrahydrofolate-homocysteine methyltransferase reductase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted secreted proteins
| | ![](/images/38113/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/38113/82212_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
FASTKD3 | FAST kinase domains 3 | | ![](/images/68525/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/68525/150653_A_2_7_rna_selected_60x60.jpg) | Expressed in all |
SEMA5A | Sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A | Predicted membrane proteins Predicted secreted proteins
| ![](/images/4632/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/4632/13605_B_7_7_rna_selected_60x60.jpg) | Mixed |
TAS2R1 | Taste receptor, type 2, member 1 | G-protein coupled receptors Predicted membrane proteins
| ![](/images/51879/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/51879/ihc_cell_selected_60x60.jpg) | ![](/images/51879/117901_B_8_3_rna_selected_60x60.jpg) | Tissue enriched |
FAM173B | Family with sequence similarity 173, member B | Predicted membrane proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Expressed in all |
CCT5 | Chaperonin containing TCP1, subunit 5 (epsilon) | Disease related genes Plasma proteins
| | | | ![](/images/6271/18268_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
CMBL | Carboxymethylenebutenolidase homolog (Pseudomonas) | | ![](/images/36571/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/36571/77408_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
MARCH6 | Membrane-associated ring finger (C3HC4) 6, E3 ubiquitin protein ligase | Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/63246/141730_A_8_6_rna_selected_60x60.jpg) | Expressed in all |
ROPN1L | Rhophilin associated tail protein 1-like | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/41830/147865_B_8_5_rna_selected_60x60.jpg) | Group enriched |